
    
      Evaluation of Safety, PK and PD of ISIS 416858 in patients with end-stage renal disease
      (ESRD) receiving chronic hemodialysis.

      The overall objectives are to evaluate the safety, tolerability, pharmacokinetics, and
      pharmacodynamics of ISIS 416858 in ESRD patients on hemodialysis.
    
  